Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Review

Published on 21 Mar 2023

Treatment strategies for clear cell renal cell carcinoma: Past, present and future

in Cancer Molecular Targets and Therapeutics

Junwei Yang
Kuansong Wang
Zhichun Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1133832

19,408 views
40 citations

Mini Review

Published on 17 Mar 2023

In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders

in Cancer Molecular Targets and Therapeutics

David O. Kamson
Viveka Chinnasamy
Stuart A. Grossman
Chetan Bettegowda
Peter B. Barker
Peter W. Stacpoole
Georg Oeltzschner

Frontiers in Oncology

doi 10.3389/fonc.2023.1077461

3,334 views
7 citations

Original Research

Published on 14 Mar 2023

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma

in Cancer Molecular Targets and Therapeutics

Cristina Di Giorgio
Rachele Bellini
Antonio Lupia
Carmen Massa
Martina Bordoni
Silvia Marchianò
Rosalinda Rosselli
Valentina Sepe
Pasquale Rapacciuolo
Federica Moraca

Frontiers in Oncology

doi 10.3389/fonc.2023.1140730

5,610 views
10 citations

Original Research

Published on 13 Mar 2023

High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer

in Cancer Molecular Targets and Therapeutics

Lei Chen
Yiyi Ji
Ang Li
Bo Liu
Kai Shen
Ruopeng Su
Zehua Ma
Weiwei Zhang
Qi Wang
Yinjie Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1085569

3,634 views
6 citations

Original Research

Published on 10 Mar 2023

Loss of liver kinase B1 in human seminoma

in Cancer Molecular Targets and Therapeutics

Manish Kumar
Subhransu S. Sahoo
M. Fairuz B. Jamaluddin
Pradeep S. Tanwar

Frontiers in Oncology

doi 10.3389/fonc.2023.1081110

1,221 views

Original Research

Published on 10 Mar 2023

LIM1 contributes to the malignant potential of endometrial cancer

in Cancer Molecular Targets and Therapeutics

Hiroaki Kato
Noritaka Saeki
Matome Imai
Hiroshi Onji
Akiko Yano
Shuhei Yoshida
Tomohisa Sakaue
Toru Fujioka
Takashi Sugiyama
Yuuki Imai

Frontiers in Oncology

doi 10.3389/fonc.2023.1082441

2,539 views
3 citations

Original Research

Published on 08 Mar 2023

PSGL-1 is a novel tumor microenvironment prognostic biomarker with cervical high-grade squamous lesions and more

in Cancer Molecular Targets and Therapeutics

Yingying Lin
Shan Huang
Yuanjie Qi
Li Xie
Junying Jiang
Hua Li
Zhiwei Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1052201

2,673 views
9 citations

Review

Published on 07 Mar 2023

Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges

in Cancer Molecular Targets and Therapeutics

Pengxiao Su
Ming Zhang
Xin Kang

Frontiers in Oncology

doi 10.3389/fonc.2023.1071030

4,624 views
8 citations

Original Research

Published on 07 Mar 2023

JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer

in Cancer Molecular Targets and Therapeutics

Jogendra Singh Pawar
Md. Yusuf Al-Amin
Chang-Deng Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1126482

3,227 views
3 citations

Systematic Review

Published on 03 Mar 2023

Prognostic value of nectin-4 in human cancers: A meta-analysis

in Cancer Molecular Targets and Therapeutics

Rongqiang Liu
Kailiang Zhao
Kunpeng Wang
Lilong Zhang
Wangbin Ma
Zhengdong Qiu
Weixing Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1081655

4,628 views
7 citations

Original Research

Published on 03 Mar 2023

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)

in Cancer Molecular Targets and Therapeutics

Xinyu Zhai
Xinglin Chen
Zhong Wan
Minyao Ge
Yi Ding
Jianyi Gu
Jinjun Hua
Dongdong Guo
Mingyue Tan
Dongliang Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1136835

4,671 views
10 citations

Original Research

Published on 28 Feb 2023

Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study

in Cancer Molecular Targets and Therapeutics

Federica Ferrarini
Elisabetta Zulato
Massimo Moro
Paola Del Bianco
Cristina Borzi
Giovanni Esposito
Tiziana Zanin
Gabriella Sozzi
Stefano Indraccolo

Frontiers in Oncology

doi 10.3389/fonc.2023.1070505

2,260 views
2 citations

Original Research

Published on 27 Feb 2023

Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates

in Cancer Molecular Targets and Therapeutics

Ye-Jin Kim
Wei Li
Doncho V. Zhelev
John W. Mellors
Dimiter S. Dimitrov
Du-San Baek

Frontiers in Oncology

doi 10.3389/fonc.2023.1124039

7,144 views
13 citations

Original Research

Published on 27 Feb 2023

Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital

in Cancer Molecular Targets and Therapeutics

Sandra Pinet
Stéphanie Durand
Alexandre Perani
Léa Darnaud
Fifame Amadjikpe
Mathieu Yon
Tiffany Darbas
Alain Vergnenegre
Thomas Egenod
Yannick Simonneau

Frontiers in Oncology

doi 10.3389/fonc.2023.1104659

2,305 views
5 citations

Original Research

Published on 23 Feb 2023

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis

in Cancer Molecular Targets and Therapeutics

Andrea Caddeo
Marina Serra
Francesca Sedda
Andrea Bacci
Clementina Manera
Simona Rapposelli
Amedeo Columbano
Andrea Perra
Marta Anna Kowalik

Frontiers in Oncology

doi 10.3389/fonc.2023.1127517

4,898 views
7 citations

Original Research

Published on 23 Feb 2023

Association of circulating tumor cells and IMP3 expression with metastasis of osteosarcoma

in Cancer Molecular Targets and Therapeutics

Shuangwu Dai
Xinxin Shao
Qingzhu Wei
Shaohua Du
Changhe Hou
Haomiao Li
Dadi Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.819357

2,385 views
9 citations